Related Experiment Videos
In utero gene therapy: prospect and future
D P Chauhan1, A S Srivastava, M E Moustafa
1Department of Medicine, School of Medicine, University of California San Diego, USA. dchauhan@ucsd.edu
Current Pharmaceutical Design
|December 8, 2004
Summary
In utero gene therapy offers early intervention for fetal genetic disorders, potentially preventing lifelong damage. While promising in animal models, human clinical trials require further research and ethical considerations.
Area of Science:
- Medical Genetics
- Developmental Biology
- Gene Therapy
Background:
- Genetic disorders can cause irreversible fetal damage before birth.
- In utero gene therapy presents a potential solution for correcting these defects early.
- Fetal cells' rapid replication and underdeveloped immune system may enhance therapy efficacy.
Purpose of the Study:
- To review the progress of in utero gene therapy.
- To identify research gaps before human clinical application.
- To address ethical considerations for fetal gene therapy trials.
Main Methods:
- Review of existing literature on in utero gene transfer.
- Analysis of animal model successes and limitations.
- Discussion of ethical and regulatory challenges.
Main Results:
- Successful in utero gene transfer demonstrated in animal models.
- Fetal gene therapy offers advantages like early intervention and potentially reduced immune response.
- Significant research and ethical hurdles remain before human application.
Conclusions:
- In utero gene therapy holds promise for treating fetal genetic disorders.
- Further research is essential to ensure safety and efficacy in humans.
- Robust ethical frameworks and competent oversight are critical for future trials.